Korean J Pathol.  2001 Dec;35(6):470-476.

Primary Nodal Marginal Zone B-cell Lymphoma: Clincopathologic Analysis of Splenic and Mucosa-Associated Lymphoid Tissue Type

Affiliations
  • 1Department of Diagnostic Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea. yhko@smc.samsung.co.kr
  • 2Department of Pathology, Chungang University School of Medicine, Korea
  • 3Department of Pathology, Eulji University School of Medicine, Seoul 135-710, Korea.

Abstract

BACKGROUND
Primary nodal marginal zone B-cell lymphoma (MZBL) is recently divided into mucosa-associated lymphoid tissue (MALT) type and splenic type. Herein, we analyzed clinicopathologic differences of those two types of nodal MZBL.
METHODS
Histologic and clinical findings of eleven cases of primary nodal MZBL lymphoma were reviewed. Immunohistochemical stains for IgD, Ki-67, CD3, and CD20 were performed.
RESULTS
The cases were classified as splenic type in four, MALT type in five, and unclassified in two. The age at presentation was 36.7 years old (range: 16-73) in splenic type and 48 years old (range: 31-68) in MALT type. Two patients with splenic type and one with MALT type had a long history of lymphadenopathy up to 9 years. Whereas tumors of splenic type showed nodular infiltration of tumor cells with follicular colonization and hyperplastic germinal center, tumors of MALT type showed mainly sinusoidal or parafollicular infiltration and atrophic germinal centers. All the patients with splenic type were alive at last follow-up and one patient with MALT type died of disease at 5 months after diagnosis.
CONCLUSIONS
Although the number of cases we analyzed was small, splenic type seems to be distinct from MALT type and lower grade neoplasm.

Keyword

Lymphoma; Pathology

MeSH Terms

Colon
Coloring Agents
Diagnosis
Follow-Up Studies
Germinal Center
Humans
Immunoglobulin D
Lymphatic Diseases
Lymphoid Tissue*
Lymphoma
Lymphoma, B-Cell, Marginal Zone*
Middle Aged
Pathology
Coloring Agents
Immunoglobulin D
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr